imiquimod has been researched along with Alopecia Areata in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Guimaraens, B; Dominguez-Santas, M; Hermosa-Gelbard, Á; Moreno-Arrones, ÓM; Saceda-Corralo, D; Suarez-Valle, A; Vañó-Galván, S | 1 |
| Borowska, K; Wasyłyszyn, T | 1 |
| Akar, A; Koc, E; Kurumlu, Z; Tunca, M | 1 |
3 other study(ies) available for imiquimod and Alopecia Areata
| Article | Year |
|---|---|
Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata.
Topics: Adult; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Female; Hair; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Male; Treatment Outcome | 2022 |
Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Aminoquinolines; Child; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Photosensitizing Agents; Retreatment; Young Adult | 2017 |
Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Alopecia Areata; Aminoquinolines; Female; Humans; Imiquimod; Male; Severity of Illness Index; Young Adult | 2008 |